Overview

Obesity has long been recognized as a chronic disease-but its treatment is undergoing a historic transformation. What began with weekly injections is now evolving into a new generation of oral medications. The switch from syringes to tablets is much more than a question of application. It marks a profound paradigm shift in medicine, the market, and society. This book analyzes the latest pharmacological developments, explains the biological mechanisms of action of modern incretin and multi-hormone strategies, and highlights the long-term consequences of potentially permanent drug-based weight control. What does it mean if weight regulation is pharmacologically controlled for life in the future, like high blood pressure or diabetes? What opportunities will arise - and what new dependencies? Well-researched and written in a way that is easy to understand, this work combines current study data, regulatory perspectives, and health policy considerations with a critical reflection on the chronic nature of obesity therapy. It is aimed at those affected, those interested in medicine, experts, and anyone who wants to understand how much the transition from injections to tablets could change the future of weight medicine. The next generation of weight loss therapy is not only more convenient-it could fundamentally redefine our understanding of disease, responsibility, and lifelong treatment. Bremen University Press has published over 5,500 specialist books since 2005. This book is available in German, English, French, Spanish, and Italian. February 2026

Full Product Details

9783691737493

Table of Contents

Reviews

Author Information

Tab Content 6

Countries Available